New Drug Compounding Voice Emerges In Opposition To Federal Action

FDA Week - 03/15/2013

A private company that supplies equipment and chemicals to compounding pharmacies is vociferously opposing any federal action -- from Congress or FDA -- on drug compounding, asserting that state boards of pharmacy have clear authority as the sole regulators with jurisdiction over the practice. The company, Professional Compounding Centers of America, has clients that are also part of compounders' main lobby group, the International Academy of Compounding Pharmacists, although the company diverges from IACP on key points in asserting that federal legislation is not necessary and FDA had no role in overseeing events that led to a nationwide meningitis outbreak.964 words Subscription required here